Beyond AMR—The Hidden Cost Of Antibiotics On Immunity

Antimicrobial resistance (AMR) dominates discussions about antibiotic use in animal agriculture. Policymakers, veterinarians, producers and consumers are primarily concerned with resistant bacteria that threaten human, animal and environmental health. While AMR is undeniably critical, it is not the only problem associated with routine antibiotic use. Beyond resistance lies a hidden cost: antibiotics can compromise the animal's immune system.

The Immune System's Delicate Balance

The immune system in livestock is a sophisticated defense network composed of innate and adaptive components. Innate immunity provides immediate, non-specific protection through physical barriers, phagocytes, and inflammatory responses. Adaptive immunity delivers targeted, long-lasting defense via B cells, T cells, and antibodies.

Both forms of immunity rely on balanced microbial signaling. The gut microbiome acts as a “training ground” for immune development. Commensal bacteria—beneficial microorganisms that live naturally in the gastrointestinal tract without harming the host—stimulate immune maturation, promote regulatory T cell development, and maintain mucosal barrier integrity. Disrupting this microbial ecosystem impairs immune responsiveness, making animals more susceptible to infections and increasing the likelihood of antibiotic use.

Antibiotics, by design, reduce bacterial populations. Broad-spectrum antibiotics in particular wipe out beneficial bacteria alongside harmful ones, disturbing the microbial-immune balance essential for healthy immunity.

HOW ANTIBIOTICS COMPROMISE IMMUNE FUNCTION

Microbiome Disruption And Immune Dysregulation

The gut microbiome exerts a profound influence on immune cell differentiation, activation, and overall function. Commensal bacteria produce metabolites such as short-chain fatty acids (SCFAs)—particularly butyrate, propionate, and acetate—which directly regulate immune cell development and cytokine production. These microbial signals are essential for the maturation of dendritic cells, the polarization of T helper cells, and the differentiation of regulatory T cells that prevent excessive inflammation.

Research in poultry provides compelling evidence of this relationship. Studies demonstrate that antibiotic-mediated depletion of key beneficial bacterial genera—specifically Lactobacillus, Bifidobacterium, and beneficial Clostridium clusters—produces measurable immunological deficits. Antibiotic-treated birds show significant reductions in secretory IgA production, the primary immunoglobulin protecting mucosal surfaces in the gut. Macrophage activity is diminished, resulting in impaired phagocytosis and reduced pathogen clearance. Natural killer cell cytotoxicity decreases, and the production of pro-inflammatory cytokines such as IL-6 and TNF-alpha becomes dysregulated. Most critically, mucosal immunity—the first line of defense against enteric pathogens—is severely weakened. This cascade of immune dysfunction leaves birds more vulnerable to infections by Salmonella, Campylobacter, E. coli, and Clostridium perfringens, potentially necessitating additional antibiotic interventions and perpetuating a cycle of dependency.

Impaired Vaccine Responses

A functioning gut microbiome is essential for optimal vaccine efficacy. Research shows that antibiotic-treated chicks  have reduced antibody titers after Newcastle disease and infectious bursal disease vaccination. Similarly, nursery pigs given antibiotics exhibit compromised  immune responses to porcine reproductive and respiratory syndrome (PRRS) vaccines.

The mechanism is well-established: without microbial stimulation, antigen-presenting cells are less active, T cell priming is suboptimal, and B cell antibody production is diminished. Antibiotics, paradoxically, can leave vaccinated animals more vulnerable to the very diseases they were meant to prevent.

Increased Susceptibility To Opportunistic Pathogens

When beneficial microbes are depleted, opportunistic pathogens fill the ecological void. Clostridioides difficile, Salmonella, and Campylobacter can thrive in antibiotic-disrupted microbiomes. In poultry, antibiotic use has been associated with increased E. coli colibacillosis incidence despite an overall reduction in bacterial load overall.

This phenomenon, called “colonization resistance loss,” occurs when commensal bacteria no longer compete effectively for nutrients and attachment sites. The immune system, already weakened by microbial imbalance, struggles to control these invaders, leading to secondary infections that require even more antibiotic intervention—a vicious cycle.

Chronic Inflammation And Immune Exhaustion

Antibiotic-induced dysbiosis triggers persistent gut inflammation. Leaky gut allows bacterial lipopolysaccharides (LPS) to enter circulation, activating systemic immune responses. Chronic immune activation diverts energy from growth and production toward inflammation management.

In commercial broilers, antibiotic-treated groups show elevated heterophil-to-lymphocyte ratios, a marker of chronic stress and immune activation. Over time, this immune exhaustion reduces disease resilience, diminishes feed efficiency, and increases mortality—undermining the productivity gains antibiotics were meant to deliver.

EVIDENCE FROM FIELD AND RESEARCH

Poultry Studies

• Broad-spectrum antibiotic treatment in the drinking water (day 1-7, or day 1-14) of day-old chicks significantly reduced (p < 0.01) serum IgA content compared to controls, and disrupted gut barrier structure and immune functions (Ghafoor et al., 2024).

• Adding ceftiofur to an avian influenza vaccine reduced H5N8 and H7N9 antibody titres after the first immunization (p < 0.05) and H7N9 antibody titers after the second immunization (p < 0.01). (Shen et al., 2024).

• Oral administration of florfenicol (days 1-7)—commonly used in poultry production to prevent and treat Salmonella infection—to day-old chicks altered intestinal microbiota and metabolite profiles, reducing colonization resistance to Salmonella infection (Mei et al., 2021).

• Antibiotic exposure reduced gut microbiota diversity and disrupted community stability, however, the impacts of different antibiotics differed considerably, with florfenicol, gentamicin, and benzylpenicillin having the most significant and long-lasting effects (Zhan et al., 2025).

Swine Studies

• Antibiotic intervention at day 7  in piglets increased  counts of Enterobacteriaceae (which are opportunistic pathogens or indicator organisms of dysbiosis) at day 77 and decreased  beneficial Bifidobacterium (day 77) and Clostridium cluster XIVa (day 120)  in the jejunum and ileum (Zhang et al., 2020).

• Four-day old piglets treated with antibiotics for lung infections had lower gut bacterial diversity (Shannon index) at day 176 compared with controls and the treatment group had less well-developed immune systems (Schokker et al., 2015).

• Although antibiotics caused only a transient disruption in gut-associated microbial communities, the implications were long-term, with antibiotic-treated neonatal piglets mounting an upregulated response to an immune challenge (Fouhse et al., 2019). This research adds to the growing body of evidence indicating adverse immune outcomes of early-life antibiotic exposures.

• These data reveal a consistent pattern: antibiotics reduce microbial diversity, impair immune maturation, and increase disease susceptibility—offsetting their short-term therapeutic benefits.

ONE HEALTH IMPLICATIONS

The immune cost of antibiotics extends beyond individual animals. Immune-compromised flocks and herds harbor more pathogens, increasing environmental contamination and risk of zoonotic transmission. Humans handling livestock or consuming products from immune-stressed animals face higher exposure to opportunistic pathogens.

Furthermore, immune suppression can accelerate AMR evolution. Stressed immune systems allow bacteria to persist longer, increasing opportunities for resistance gene exchange. Thus, antibiotic use creates a dual threat: weakened immunity and stronger resistance.

FINAL THOUGHTS

Antibiotic resistance is only part of the story. The hidden cost of antibiotics—immune system compromise—also threatens animal, public and environmental health. Disrupted microbiomes, impaired vaccine responses, increased opportunistic infections, and chronic inflammation all stem from antibiotic-induced immune suppression.

Addressing this hidden cost requires a paradigm shift from antibiotic-dependent production to microbiome-centered, immunity-supporting nutrition and management. This means nurturing beneficial gut bacteria, with feed additives such as probiotics, prebiotics, phytogenics, and organic acids, while implementing strict biosecurity and hygiene protocols to lower pathogen loads before they challenge the immune system. By embracing a One Health approach, antibiotics will become the exception—not the foundation--- of sustainable animal agriculture.

WANT TO KNOW MORE?

This technical article is part of Ecolex Animal Nutrition’s continuing knowledge transfer efforts, supporting more sustainable and resilient animal production systems.

Follow us at www.ecolex.com as we share more actionable One Health insights and strategies for building a more secure, resilient food system from farm to fork.

References available on request.